Pfizer and Zhejiang Hisun formed the JV Hisun-Pfizer Pharmaceuticals Co. Ltd. to manufacture and commercialize generics in China and to conduct R&D of off-patent medicines

Pfizer Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Zhejiang Hisun Pharmaceutical Co. Ltd.

China / Small-Cap Biopharma (<$1 billion)

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced